Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anxut
2. Apo Buspirone
3. Apo-buspirone
4. Bespar
5. Busp
6. Buspar
7. Buspirone
8. Gen Buspirone
9. Gen-buspirone
10. Hydrochloride, Buspirone
11. Lin Buspirone
12. Lin-buspirone
13. Mj 9022 1
14. Mj-9022-1
15. Mj90221
16. N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
17. Neurosine
18. Novo Buspirone
19. Novo-buspirone
20. Nu Buspirone
21. Nu-buspirone
22. Pms Buspirone
23. Pms-buspirone
24. Ratio Buspirone
25. Ratio-buspirone
1. 33386-08-2
2. Buspar
3. Buspirone Hcl
4. Narol
5. Buspimen
6. Buspirone (hydrochloride)
7. Mj 9022-1
8. 8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione Hydrochloride
9. Nsc-751138
10. Nsc-759571
11. Mj-9022-1
12. Mls000069796
13. N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide Monohydrochloride
14. 207lt9j9oc
15. Apd405
16. Chebi:3224
17. Apd-405
18. Ansitec
19. Anxinil
20. Anxiolan
21. Busirone
22. Buspinol
23. Censpar
24. Effiplen
25. Establix
26. Kallmiren
27. Lucelan
28. Mabuson
29. Normaton
30. Smr000058186
31. Spamilan
32. Barpil
33. Bespar
34. Itagil
35. Nerbet
36. Sburol
37. Travin
38. Tutran
39. Biron
40. Relac
41. 33386-08-2 (hcl)
42. Apo-buspirone
43. 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
44. 8-azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, Monohydrochloride
45. 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione Hydrochloride
46. 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione Hydrochloride
47. Buspirone Hydrochloride [usan]
48. Sr-01000075541
49. Einecs 251-489-4
50. Unii-207lt9j9oc
51. C21h31n5o2.hcl
52. Prestwick_711
53. Buspirone Hydrochloride [usan:usp]
54. Buspar (tn)
55. Mfcd00078569
56. Opera_id_707
57. 1,1-cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, Hydrochloride
58. 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione Hydrochloride
59. Schembl41495
60. Mls001076085
61. Mls002548862
62. Buspirone Hydrochloride (usp)
63. Buspirone Hydrochloride Solution
64. Buspirone For System Suitability
65. Chembl1200399
66. Dtxsid1037193
67. Hms1569i19
68. Hms3750o03
69. Pharmakon1600-02300173
70. Apc-6002
71. Apc-6003
72. Bcp28463
73. Hy-b1115
74. Buspirone Hydrochloride [mi]
75. Tox21_500223
76. Buspirone Hydrochloride [jan]
77. Nsc751138
78. Nsc759571
79. S4256
80. Akos015962019
81. Ac-1905
82. Buspirone Hydrochloride [mart.]
83. Buspirone Hydrochloride [vandf]
84. Ccg-213652
85. Cs-4714
86. H05b847
87. Ks-5163
88. Lp00223
89. Nc00673
90. Nsc 751138
91. Nsc 759571
92. Buspirone Hydrochloride [usp-rs]
93. Buspirone Hydrochloride [who-dd]
94. Ncgc00093692-01
95. Ncgc00093692-02
96. Ncgc00260908-01
97. 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione Monohydrochloride
98. Buspirone Hydrochloride [orange Book]
99. Eu-0100223
100. Sw155073-5
101. Buspirone Hydrochloride [ep Monograph]
102. B 7148
103. Buspirone Hydrochloride [usp Monograph]
104. D00702
105. D96810
106. Q-200768
107. Sr-01000075541-1
108. Sr-01000075541-3
109. Sr-01000075541-7
110. Q27105997
111. Buspirone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
112. Buspirone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
113. Buspirone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
114. 8-azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, Monohydrochloride
115. Buspirone For System Suitability, European Pharmacopoeia (ep) Reference Standard
116. Buspirone Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
117. 1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium Chloride
118. 8-[4-[4-(2-pyrimidinyl)-1-pipirazin Yl]butyl]-8-azaspiro[4,5]decane-7,9-dione Hydrochloride
119. 8-[4-[4-(2-pyrimidinyl)-1-pipirazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione Hydrochloride
120. 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione Hydrochloride
121. 8-azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, Hydrochloride (1:1)
122. Buspirone Hcl Pound>>mj 9022 1 Pound>> Mj-9022-1 Pound>>mj90221 Pound>>mj9022 1 Pound>>mj9022-1
123. Buspirone Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 422.0 g/mol |
---|---|
Molecular Formula | C21H32ClN5O2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 421.2244530 g/mol |
Monoisotopic Mass | 421.2244530 g/mol |
Topological Polar Surface Area | 69.6 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 529 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Buspirone hydrochloride |
Drug Label | Buspirone hydrochloride tablets USP are an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs.Buspirone hydrochloride is a white crystalline, water soluble co... |
Active Ingredient | Buspirone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 5mg; 7.5mg; 30mg; 10mg; 15mg |
Market Status | Prescription |
Company | Watson Labs; Teva; Zydus Pharms Usa; Strides Arcolab; Dr Reddys Labs; Prosam Labs; Mylan |
2 of 2 | |
---|---|
Drug Name | Buspirone hydrochloride |
Drug Label | Buspirone hydrochloride tablets USP are an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs.Buspirone hydrochloride is a white crystalline, water soluble co... |
Active Ingredient | Buspirone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 5mg; 7.5mg; 30mg; 10mg; 15mg |
Market Status | Prescription |
Company | Watson Labs; Teva; Zydus Pharms Usa; Strides Arcolab; Dr Reddys Labs; Prosam Labs; Mylan |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
GDUFA
DMF Review : Complete
Rev. Date : 2016-07-28
Pay. Date : 2016-07-21
DMF Number : 11148
Submission : 1994-10-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-05-13
Pay. Date : 2014-01-20
DMF Number : 25361
Submission : 2011-11-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12172
Submission : 1996-10-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8928
Submission : 1991-01-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6418
Submission : 1986-06-02
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-04
Pay. Date : 2013-09-26
DMF Number : 9167
Submission : 1991-06-11
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9802
Submission : 1992-07-22
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5397
Submission : 1984-05-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4241
Submission : 1981-07-29
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : R0-CEP 2021-262 - Rev 00
Status : Valid
Issue Date : 2022-10-27
Type : Chemical
Substance Number : 1711
Certificate Number : CEP 2023-395 - Rev 00
Status : Valid
Issue Date : 2025-02-12
Type : Chemical
Substance Number : 1711
Certificate Number : CEP 2021-174 - Rev 01
Status : Valid
Issue Date : 2024-05-24
Type : Chemical
Substance Number : 1711
Certificate Number : CEP 2022-151 - Rev 01
Status : Valid
Issue Date : 2024-11-05
Type : Chemical
Substance Number : 1711
Busipirone Hydrochloride IP/USP/EP
Date of Issue : 2024-04-23
Valid Till : 2027-04-22
Written Confirmation Number : WC-0170
Address of the Firm : Plot No. 41, 42/2, 42/1/B, 43, 40, 59, 58 GIDC, Vapi, Dist: Valsad -396195, Guja...
Buspirone Hydrochloride Ph.Eur
Date of Issue : 2024-05-29
Valid Till : 2027-03-04
Written Confirmation Number : WC-0294
Address of the Firm : 120 A & B, 120P and 121, Industrial Area, Baikampady, New Mangalore -575011, Ind...
Date of Issue : 2024-05-29
Valid Till : 2027-03-04
Written Confirmation Number : WC-0294
Address of the Firm : 120 A & B, 120P and 121, Industrial Area, Baikampady, New Mangalore -575011, Ind...
Date of Issue : 2022-06-17
Valid Till : 2025-07-21
Written Confirmation Number : WC-0062
Address of the Firm : Plot No. 197, Sector - I, Pithampur, Dist. Dhar, Madhya Pradesh
Date of Issue : 2022-06-17
Valid Till : 2025-07-21
Written Confirmation Number : WC-00062A2
Address of the Firm : Plot No. 197, Sector-1, Pithampur- 454 775, District- Dhar, Madhya Pradesh, Indi...
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2018-10-11
Registration Number : 20181011-209-J-136
Manufacturer Name : Excella GmbH & Co. KG
Manufacturer Address : Nurnberger Str. 12, 90537 Feucht, Germany
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-12-28
Registration Number : 20211228-209-J-1093
Manufacturer Name : Solara Active Pharma Science...
Manufacturer Address : 120 A&B, 120P & 121, Industrial Area Baikampady New Mangalore – 575 011, Karnataka,...
NDC Package Code : 12780-2940
Start Marketing Date : 1994-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1068
Start Marketing Date : 2012-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2845
Start Marketing Date : 2010-11-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 50218-013
Start Marketing Date : 2024-04-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 71666-013
Start Marketing Date : 2023-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0169
Start Marketing Date : 2018-12-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 72643-036
Start Marketing Date : 2023-07-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-1310
Start Marketing Date : 2006-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-040
Start Marketing Date : 2015-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65841-136
Start Marketing Date : 2024-11-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & F...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Unimark Remedies Ltd is a leading API manufacturer with over 18 years of excellence, now fully owned by Shamrock Pharma Group. We provide affordable generic APIs for local and glob...
About the Company : Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent ...
About the Company : Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes rangi...
About the Company : Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of ma...
About the Company : Medilux Laboratories has been providing quality back-end support to the pharmaceutical industry since our inception in 1988. Our resources are dedicated to promoting better health ...
About the Company : Established in 1984, R L Fine Chem Pvt. Ltd. is one of the fastest growing API companies, with a leadership position in several APIs such as antihistamines, antidepressants and mus...
About the Company : Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API e...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : Anksilon
Dosage Form : TABLET
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Anksilon
Dosage Form : TABLET
Dosage Strength : 5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Buspirone Actavis
Dosage Form : TABLET
Dosage Strength : 5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Buspirone Actavis
Dosage Form : TABLET
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Buspirone Mylan
Dosage Form : TABLET
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Buspirone Mylan
Dosage Form : TABLET
Dosage Strength : 5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Buspirone 2care4
Dosage Form : TABLET
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
95
PharmaCompass offers a list of Buspirone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Buspirone Hydrochloride manufacturer or Buspirone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Buspirone Hydrochloride manufacturer or Buspirone Hydrochloride supplier.
PharmaCompass also assists you with knowing the Buspirone Hydrochloride API Price utilized in the formulation of products. Buspirone Hydrochloride API Price is not always fixed or binding as the Buspirone Hydrochloride Price is obtained through a variety of data sources. The Buspirone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bespar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bespar, including repackagers and relabelers. The FDA regulates Bespar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bespar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bespar manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bespar supplier is an individual or a company that provides Bespar active pharmaceutical ingredient (API) or Bespar finished formulations upon request. The Bespar suppliers may include Bespar API manufacturers, exporters, distributors and traders.
click here to find a list of Bespar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bespar DMF (Drug Master File) is a document detailing the whole manufacturing process of Bespar active pharmaceutical ingredient (API) in detail. Different forms of Bespar DMFs exist exist since differing nations have different regulations, such as Bespar USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bespar DMF submitted to regulatory agencies in the US is known as a USDMF. Bespar USDMF includes data on Bespar's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bespar USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bespar suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bespar Drug Master File in Korea (Bespar KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bespar. The MFDS reviews the Bespar KDMF as part of the drug registration process and uses the information provided in the Bespar KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bespar KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bespar API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bespar suppliers with KDMF on PharmaCompass.
A Bespar CEP of the European Pharmacopoeia monograph is often referred to as a Bespar Certificate of Suitability (COS). The purpose of a Bespar CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bespar EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bespar to their clients by showing that a Bespar CEP has been issued for it. The manufacturer submits a Bespar CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bespar CEP holder for the record. Additionally, the data presented in the Bespar CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bespar DMF.
A Bespar CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bespar CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bespar suppliers with CEP (COS) on PharmaCompass.
A Bespar written confirmation (Bespar WC) is an official document issued by a regulatory agency to a Bespar manufacturer, verifying that the manufacturing facility of a Bespar active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bespar APIs or Bespar finished pharmaceutical products to another nation, regulatory agencies frequently require a Bespar WC (written confirmation) as part of the regulatory process.
click here to find a list of Bespar suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bespar as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bespar API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bespar as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bespar and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bespar NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bespar suppliers with NDC on PharmaCompass.
Bespar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bespar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bespar GMP manufacturer or Bespar GMP API supplier for your needs.
A Bespar CoA (Certificate of Analysis) is a formal document that attests to Bespar's compliance with Bespar specifications and serves as a tool for batch-level quality control.
Bespar CoA mostly includes findings from lab analyses of a specific batch. For each Bespar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bespar may be tested according to a variety of international standards, such as European Pharmacopoeia (Bespar EP), Bespar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bespar USP).